Presenilin 2 Mutation Does Not Influence Expression and Concentration of APP Forms in Human Platelets

Molecular Medicine

Volumn 6, Issue 10, 2000, Pages 816-824

  Pastorino, Lucia ^a   Colciaghi, Francesca ^a   Marcon, Gabriella ^b   Borroni, Barbara ^c   Cottini, Elisabetta ^c   Cattabeni, Flaminio ^a   Padovani, Alessandro ^c   Di Luca, Monica ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Amyloid Cascade; Platelet APP; Platelet Homogenates; Presenilin (PS2); Val30Met Mutation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; PRESENILIN 2; PRIMER DNA; PSEN2 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; GENETICS; HUMAN; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; HUMANS; MEMBRANE PROTEINS; MUTATION; PRESENILIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MLCS; MLOWN;

EID: 0034295199     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401820     Document Type: Article

References (41)

1. D. Goldgaber M.I. Lerman O.W. McBride U. Saffiotti D.C. Gajdusek Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease Science 1987 235 877 880 10.1126/science.3810169 1:CAS:528:DyaL2sXhtlaru70%3D 3810169
2. R.E. Tanzi J.F. Gusella P.C. Watkins et al. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus Science 1987 235 880 884 10.1126/science.2949367 1:CAS:528:DyaL2sXhtlaru7o%3D 2949367
3. S. Lammich E. Kojro R. Postina et al. Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease Proc. Natl. Acad. Sci. U.S.A. 1999 96 3922 3927 10.1073/pnas.96.7.3922 1:CAS:528:DyaK1MXjslChsLY%3D 10097139 22396
4. J.D. Buxbaum K.N. Liu X. Luo et al. Evidence that tumor necrosis factor (α-converting enzyme is involved in regulated (α-secretase cleavage of the Alzheimer amyloid precursor protein J. Biol. Chem. 1998 273 27765 27767 10.1074/jbc.273.43.27765 1:CAS:528:DyaK1cXntVCmtr0%3D 9774383
5. R. Vassar B.D. Bennett S. Babu-Khan et al. β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE Science 1999 286 735 741 10.1126/science.286.5440.735 1:CAS:528:DyaK1MXntFWit74%3D 10531052
6. I. Hussain D. Powell D.R. Howlett et al. Identification of a novel aspartic protease (Asp2) as β-secreatase Mol. Cell. Neurosci. 1999 14 419 427 10.1006/mcne.1999.0811 1:CAS:528:DyaK1MXnt1Chsrs%3D 10656250
7. R. Yan J.B. Bienkowski M.E. Shuck et al. Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity Nature 1999 402 533 536 10.1038/990107 1:CAS:528:DyaK1MXotFKmu7k%3D 10591213
8. S. Sinha J.P. Anderson R. Barbour et al. Purification and cloning of amyloid precursor protein β-secretase from human brain Nature 1999 402 537 540 10.1038/990114 1:CAS:528:DyaK1MXotFKlsrc%3D 10591214
9. T. Hartmann S.C. Bieger B. Bruhl et al. Distinct sites of intracellular production for Alzheimer’s disease Aβ40/42 amyloid peptides Nat. Med. 1997 3 1016 1020 10.1038/nm0997-1016 1:CAS:528:DyaK2sXlvVykt74%3D 9288729
10. C. Wild-Bode T. Yamazaki A. Capell et al. Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42 J. Biol. Chem. 1997 272 16085 16088 10.1074/jbc.272.26.16085 1:CAS:528:DyaK2sXkt1Wls7s%3D 9195901
11. J.E. Gardella J. Ghiso G.A. Gorgone et al. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA Biochem. Biophys. Res. Comm. 1990 173 1292 1298 10.1016/S0006-291X(05)80927-1 1:CAS:528:DyaK3MXnvFGruw%3D%3D 1702629
12. J.E. Gardella G.A. Gorgone P. Newman B. Frangione P.D. Gorevic Characterization of Alzheimer amyloid precursor protein transcripts in platelets and mega-karyocytes Neurosci. Lett. 1992 138 229 232 10.1016/0304-3940(92)90921-S 1:CAS:528:DyaK38XktVGnsb4%3D 1608533
13. R.P. Smith D.A. Higuchi G.J. Broze Platelet coagulation factor XIa—inhibitor, a form of Alzheimer amyloid precursor protein Science 1990 248 1126 1128 10.1126/science.2111585 1:CAS:528:DyaK3cXktlKqtLk%3D 2111585
14. Q.X. Li S. Whyte J. Tanner G. Evin K. Beyreuther C.L. Masters Secretion of Alzheimer disease Aβ amyloid peptide by activation of human platelets Lab. Invest. 1998 78 461 469 9564890 1:CAS:528:DyaK1cXivVSqtrg%3D
15. T.A. Davies R.E. Fine R.J. Johnson et al. Nonage related differences in thrombin responses by platelets from male patients with advanced Alzheimer’s disease Biochem. Biophys. Res. Commun. 1993 194 537 543 10.1006/bbrc.1993.1853 1:CAS:528:DyaK3sXkvFaqtbw%3D 8333868
16. T.A. Davies H.J. Long K. Sgro et al. Activated Alzheimer disease platelets retain more β amyloid precursor protein Neurobiol. Aging. 1997 18 147 153 10.1016/S0197-4580(97)00013-4 1:CAS:528:DyaK2sXls1Sqs7c%3D 9258891
17. T.A. Davies H.J. Long H.E. Tibbles et al. Moderate and advanced Alzheimer’s patients exhibit platelet activation differences Neurobiol. Aging 1997 18 155 162 10.1016/S0197-4580(97)00016-X 1:STN:280:DyaK2svgtlGgtA%3D%3D 9258892
18. M. Di Luca L. Pastorino A. Bianchetti et al. Differential pattern of platelet APP isoforms: an early marker for Alzheimer Disease Arch. Neurol. 1998 55 1195 1200 10.1001/archneur.55.9.1195 9740113
19. R.N. Rosenberg F. Baskin J.A. Fosmire et al. Altered amyloid protein processing in platelets of patients with Alzheimer disease Arch. Neurol. 1997 54 139 144 10.1001/archneur.1997.00550140019007 1:STN:280:DyaK2s7psVCitA%3D%3D 9041854
20. M. Di Luca L. Pastorino F. Cattabeni et al. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome Arch. Neurol. 1996 53 1162 1166 10.1001/archneur.1996.00550110114019 8912490
21. A.I. Bush R.E. Tanzi Alzheimer disease-related abnormalities of amyloid β precursor protein isoforms in the platelets—the brain delegates in the periphery Arch. Neurol. 1998 55 1179 1180 10.1001/archneur.55.9.1179 1:STN:280:DyaK1cvhtVyhtA%3D%3D 9740110
22. R. Sherrington S. Froelich S. Sorbi et al. Alzheimer disease associated with muatations in presenilin 2 is rare and variably penetrant Human Mol. Gen. 1996 5 985 988 10.1093/hmg/5.7.985 1:CAS:528:DyaK28Xkt1Cnt7s%3D
23. E. Levy-Lahad W. Wasco P. Poorkaj et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus Science 1995 269 973 977 10.1126/science.7638622 1:CAS:528:DyaK2MXnsFOmtLk%3D 7638622
24. E.I. Rogaev R. Sherrington E.A. Rogaeva et al. Familial Alzheimer’s disease in kindreds with missense mutation in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene Nature 1995 13 713 725
25. G.D. Shellenberg Genetic dissection of Alzheimer disease, a heterogenous disorder PNAS 1995 92 8552 8559 10.1073/pnas.92.19.8552
26. D. Sheuner C. Eckman M. Jensen et al. The amyloid β precursor deposited in the senile plaque of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease Nat. Med. 1996 2 864 870 10.1038/nm0896-864
27. R. Sherrington E.I. Rogaev Y. Liang et al. Cloning of a gene bearing missense mutation in early-onset familial Alzheimer’s disease Nature 1995 375 754 760 10.1038/375754a0 1:CAS:528:DyaK2MXmvVymtbo%3D 7596406
28. J.D. Buxbaum E.K. Choi Y.X. Luo et al. Calsenilin—a calcium binding protein that interacts with the presenilins and regulates the level of a presenilin fragment Nat. Med. 1998 4 1177 1181 10.1038/2673 1:CAS:528:DyaK1cXms1Ggt70%3D 9771752
29. Z. Zhang H. Hartmann V.M. Do et al. Destabilization of β-catenin by mutations in presenilin 1 potentiates neuronal apoptosis Nature 1998 395 698 702 10.1038/27208 1:CAS:528:DyaK1cXms1Ojsb4%3D 9790190
30. M. Nishimura G. Yu G. Levesque et al. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex Nat. Med. 1999 5 164 169 10.1038/5526 1:CAS:528:DyaK1MXntlWguw%3D%3D 9930863
31. G. Mc Khann D. Drachman M. Folstein R. Katzman D. Price E.M. Stadlan Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspicies of the Department of Health and Human Services Task Force on Alzheimer’s disease Neurology 1984 34 939 944 10.1212/WNL.34.7.939 1:STN:280:DyaL2c3ks1altQ%3D%3D
32. T.E. Golde S. Estes M. Usiak L. Younkin S. Younkin Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in AD using PCR Neuron 1990 4 253 267 10.1016/0896-6273(90)90100-T 1:CAS:528:DyaK3cXkslGrtL8%3D 2106330
33. M.K. Lee H.H. Slunt L.J. Martina et al. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues J. Neurosci. 1996 23 7513 7525 10.1523/JNEUROSCI.16-23-07513.1996
34. R. Vidal J. Ghiso T. Wiesniewski B. Frangione Alzheimer’s presenilin 1 gene expression in platelets and megakaryocytes. Identification of a novel splice variant FEBS Lett. 1996 393 19 23 10.1016/0014-5793(96)00845-9 1:CAS:528:DyaK28XlsFWktb4%3D 8804415
35. T.W. Kim R.E. Tanzi Presenilins and Alzheimer’s disease Curr. Opin. Neurobiol. 1997 7 683 688 10.1016/S0959-4388(97)80089-X 1:CAS:528:DyaK2sXnsVOitrc%3D 9384549
36. M.P. Mattson Q. Guo K. Furukawa W.A. Pedersen Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer disease J. Neurochem. 1998 70 1 14 10.1046/j.1471-4159.1998.70010001.x 1:CAS:528:DyaK1cXmtFyg 9422341
37. M.P. Mattson H. Zhu J. Yu M.S. Kindy Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbated calcium homeostasis J. Neurosci. 2000 20 1358 1364 10.1523/JNEUROSCI.20-04-01358.2000 1:CAS:528:DC%2BD3cXitVOktbs%3D 10662826
38. P. Vito E. Lacana L. Dadamio Interfering with apoptosis: Ca++-binding protein Alg2 and Alzheimer disease gene Alg3 Science 1996 271 521 525 10.1126/science.271.5248.521 1:CAS:528:DyaK28XmvFyqsg%3D%3D 8560270
39. B. Volozin K. Iwazaki P. Vito et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation Science 1996 274 1710 1713 10.1126/science.274.5293.1710
40. R. Crook A. Verkkoniemi J. Perez-Tur et al. A variant of Alzheimer disease with spastic paraparesis and an unusual plaques due to deletion of exon 9 of presenilin 1 Nat. Med. 1998 4 452 455 10.1038/nm0498-452 1:CAS:528:DyaK1cXisVeluro%3D 9546792
41. J.H. Li M. Xu H. Zhou J.Y. Ma H. Potter Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosome suggest a role in chromosome segregation Cell 1997 90 917 927 10.1016/S0092-8674(00)80356-6 1:CAS:528:DyaK2sXmtV2htrw%3D 9298903